A new study from ChristianaCare’s Gene Editing Institute shows that disabling a single gene with CRISPR technology can ...
Decitabine (DAC), a well-recognized DNA hypomethylating agent, has been applied to treat acute myeloid leukemia. However, clinic investigations revealed that DNA methylation reduction does not ...
Five years ago this month, in November 2020, medical history was made at Richmond Pharmacology when a patient received the ...
6d
A New Way of Stopping High Cholesterol Sounds Like Sci-Fi. Doctors Call it the "Future of Medicine."
New research breaks down how scientists use CRISPR technology to lower cholesterol. The cholesterol-lowering effects could be permanent.
Five years ago this month, in November 2020, medical history was made at London-based contract research organisation, Richmond Pharmacology, when a patient received the first CRISPR therapy delivered ...
As tech titans back startups looking to create genetically modified babies, Claudia Cockerell asks: is it about stopping ...
Hosts David and Gina explore how scientists over the centuries unlocked the ability to edit our genes ...
AZoLifeSciences on MSN
Neurons and Other Nondividing Cells Respond Differently to CRISPR-Cas9 Gene Editing
The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...
A new study shows that neurons repair CRISPR-Cas9 cuts in unique, highly predictable ways, unlike dividing cells. Researchers ...
Fanconi Anemia Market Growth Driven by Genetic Research and Healthcare Investments**Fanconi Anemia (FA) is a rare genetic disorder impacting bone marrow's ability to produce blood cells, leading to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback